CD4 and COVID-19: From an immunological point of view, the authors highlighted that, similarly to patients with sarcoidosis, BALF cell count analysis of hospitalized patients with COVID-19 showed accumulation of CD4+ and CD8+ T cells and CD4/CD8 ratio often higher than 1.5; blood lymphocytopenia was also detected.